DEFERRED FINANCING COSTS

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

DEFERRED FINANCING COSTS

9. DEFERRED FINANCING COSTS

The Company accounts for issuance costs related to its equity line of credit as a deferred asset on the condensed consolidated balance sheets, which is amortized over the life of the equity line of credit and recognized as interest expense on the consolidated statements of operations

At March 31, 2024, the carrying amount of the Company’s deferred financing costs were $2,470,605. During the three months ended March 31, 2024, the Company recognized amortization expense of $27,760.

Refer to Note 16 – Stockholders’ Equity for additional information.